Actuate’s lead investigational drug product, elraglusib (a novel GSK-3β inhibitor), targets molecular pathways ... For additional information, please visit the Company’s website at ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Haleon, the two-year-old CPG spinoff from GSK, is not only leading in marketing inclusion efforts ... It was singled out for a website that discloses the ages and genders of people included ...

Aurinia has announced a 45% workforce reduction to bolster sales of the lupus drug Lupkynis and advance the development of ...

South African retailer giant Pick n Pay has announced plans to leave Nigeria by selling its stake in A.G. LeventisThe decision comes less than 5 years after it entered the market with so much promise ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors highli ...

For example, it can play a valuable role in supporting any organisation’s sales and marketing efforts via sales clustering ..

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

Google.org, the philanthropic arm of the tech giant, has awarded a USD 1 million grant to Mumbai-based non-profit organisation Karya to boost upskilling of low-income communities. The grant will ...